XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 35,375,865 $ 37,853,947
Marketable securities 0 15,014,750
Accounts receivable 41,113 13,327,364
Prepaid and other current assets 3,131,299 2,962,903
Total current assets 38,548,277 69,158,964
Other assets    
Property and equipment, net 417,646 78,107
Right of use assets - operating leases 2,739,239 999,567
Patents and patent applications, net 10,598 11,628
Other non-current assets 234,389 179,532
Total assets 41,950,149 70,427,798
Current liabilities    
Accounts payable and accrued liabilities 3,113,068 3,369,848
Accrued salaries and wages 1,821,438 201,254
Royalty payable 0 2,920,148
Deferred revenue 0 16,618
Operating leases - current 669,209 337,690
Convertible debt - current 1,436,660 0
Total current liabilities 7,040,375 6,845,558
Long-term liabilities    
Operating leases - long term 2,083,548 673,347
Convertible debt, net of unamortized discount 12,324,237 16,069,085
Total liabilities 21,448,160 23,587,990
Stockholders' equity    
Common stock; par value $0.001; 200,000,000 shares authorized; 5,164,951 and 4,909,846 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 5,165 4,910
Additional paid-in capital 116,266,243 108,569,988
Accumulated other comprehensive loss (248,129) (54,815)
Accumulated deficit (95,521,290) (61,680,275)
Total stockholders' equity 20,501,989 46,839,808
Total liabilities and stockholders' equity $ 41,950,149 $ 70,427,798